Aldevron

AutekBio, Inc. (www.autekbio.com) is a biopharmaceutical contract development and manufacturing company (CDMO) specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. AutekBio has developed proprietary, integrated technology platforms to provide one-stop total solution “from DNA to NDA” for biopharmaceutical companies. Headquartered in the US, with manufacturing facility conveniently located in the Free Trade Zone of Beijing, AutekBio is uniquely positioned to be your trusted partner to open new frontier in the world of quality therapeutic biologics.

Our Mission: A Premier China Based Biologic CMO for the World

• No internal product development – Service Only
• No drug discovery program – CMO Only
• Serve our partners’ manufacturing needs - “from DNA to NDA”

Company Vision:

• Open new frontiers in manufacturing quality therapeutic biologics
• Deliver affordable biologics to the needed
• Gateway to Chinese market

AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO), with a relentless commitment to deliver the highest standard of service to our clients and partners.

AGC Biologics is the product of the convergence and integration of Asahi Glass Company (AGC) Life Sciences, CMC Biologics, and BIOMEVA GmbH. Our extensive network spans three continents, with cGMP-compliant facilities in Seattle, WA; Copenhagen, Denmark; Heidelberg, Germany; and Chiba, Japan.

AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics, from pre-clinical to commercial production, both mammalian and microbial. Our integrated service offerings include cell line development, bioprocess development, formulation, analytical testing, antibody drug development and conjugation, cell banking and storage, and protein expression — including our proprietary CHEF1® Expression System for mammalian production.

Our company DNA drives us to provide innovative solutions for clients to reach their goals and accelerate their projects, as well as facilitate approval and manage spending during the product lifecycle. AGC Biologics forges exceptionally strong partnerships with our clients, and we never lose sight of our commitment to deliver reliable and compliant drug substance supply, on time.

Visit www.agcbio.com to learn why AGC Biologics is a World Leader in process development and contract manufacturing.

Founded in 2002, CELPROGEN is a biotechnology company, with over 5000 products in the market, focused on developing stem cell research and therapeutics products for regenerative medicine in cardiology, oncology, diabetes & neurology. All of Celprogen’s biological products, including stem cells, cancer stem cells, iPC’s & media with specific ECM’s, are manufactured and produced in the United States of America.

CELPROGEN provides novel molecular diagnostics and therapeutic product development solutions for Biotechnology, Pharmaceutical, In-vitro diagnostics and academic partnership for drug discovery.

It has 3 divisions:

• Therapeutic Division: Focused on Drug Discovery efforts to develop Pharmaceutical agents and Drugs in the following categories: Cardiovascular, Diabetes, Neurological, Oncology,Renal and Metabolic disorders.
• Life Science Division: Provides research tools & solutions for assays, enzymes, antibodies, antigens, stem cells, Tissue culture expansion and differentiation media, primary and established cell cultures, tumor markers, cardiac markers, proteomic and genomic reagents and assay systems for life science academic and pharmaceutical communities.
• Device Division: Provides novel ELISA based assay, protein array, DNA array and cellular based assay systems that are cost effective for Research and In-vitro diagnostics Industries.

At Diagenode, a Hologic company, our goal is to build epigenetics products with pride and the highest level of performance.


Overview
Diagenode, a Hologic company, is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays. based in Liege, Belgium and NJ, USA. It was acquired by Hologic in March 2021.

The company has developed a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company's latest innovations include a unique, full automation system, the industry's most validated antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services.
► EPIGENETICS RESEARCH : Epigenetics is playing a revolutionary role in life sciences research. Diagenode continually innovates solutions and provides the highest quality epigenetics tools available.
► MOLECULAR DIAGNOSTICS : Diagenode offers amplification and quantification methods for DNA targets of human infectious disease to meet the fast-paced growth of human disease diagnostics. We also provide guidance to diagnostics companies to develop epigenetics-based diagnostics. Our products are designed to make diagnostic assays simpler, faster, and of highest quality. Our kits are CE-marked and certified ISO 9001 and ISO 13485.

Gene Universal, located in Delaware USA, is a pioneer in the field of gene synthesis and synthetic biology. As a leading company in genomics research and applied biological technology, and with our strong technical force, unparalleled customized service and fast delivery time, we are aiming to provide more cost-effective service and product to accelerate the global research in drug discovery, biology optimization, food and agriculture, etc.

Gene Universal is specialized in the area of genetic engineering, biosystem engineering and synthetic biology. By providing our industrialized and highly intensive gene synthesis platform, we could deliver both normal and complex genes in short promised time. We have also developed sophisticated software programs to design and optimize complex gene libraries and genetic systems, with these bioinformatics tools and our high-efficiency production management systems, we are able to satisfy scientific researchers with high-efficient, low-cost, and large-scale synthetic genes and genome DNA.

Meanwhile, based on our five cutting-edge expression systems: Bacterial Expression, Mammalian Expression(293 & CHO), Yeast Expression, Insect Expression and Bacillus subtilis Expression system, we have become the one-stop vendor for your gene synthesis, protein expression, and antibody production services.

Our goal is to become the global leader in DNA synthesis and synthetic area, and to achieve the prosperous prospects of making research in life science more efficient and lower cost.